Moreover, elevated EphA2/ephrin-A1 expression was associated with female gender, reduced smoking status, adenocarcinoma type, well differentiated and p-stage IA NSCLC and EGFR gene mutations[31]. This evidence concerns the gene EFNA1 and non-small cell lung carcinoma.